Spark Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Spark Investment Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-32,566	Closed	-$1.03M	–	857
2015 Q4	$1.03M	Buy	+32,566	New	+$1.15M	0.13%	236
2015 Q3	–	Sell	-25,900	Closed	-$815K	–	764
2015 Q2	$815K	Buy	25,900 +14,700	+131%	+$433K	0.11%	257
2015 Q1	$327K	Buy	+11,200	New	+$263K	0.05%	451
2014 Q3	–	Sell	-11,600	Closed	-$231K	–	741
2014 Q2	$231K	Sell	11,600 -29,700	-72%	-$573K	0.03%	466
2014 Q1	$784K	Buy	41,300 +28,545	+224%	+$593K	0.12%	269
2013 Q4	$211K	Buy	+12,755	New	+$218K	0.04%	496

Other funds holding MRTX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Spark Investment Management's MRTX Position: Q1 2016 in Review

Spark Investment Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2016, closing a stake of 32,566 shares — an estimated $1.03M sold.

Spark Investment Management first reported a position in MRTX in Q4 2013 and held it in 6 quarters. The position peaked at $1.03M in Q4 2015. 68 funds tracked by Wall St. Rank hold MRTX as of Q1 2016.

Spark Investment Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
Spark Investment Management sold 32,566 Mirati Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $1.03M.
Spark Investment Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2013 and held it in 6 quarters.
Spark Investment Management's Mirati Therapeutics, Inc. Common Stock position peaked at $1.03M in Q4 2015.
68 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.